| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.19 | 0.5 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.5 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.031 | 0.5 |